We are live on ! Find out more
LABU icon

Direxion Daily S&P Biotech Bull 3X ETF
LABU

51 hedge funds and large institutions have $27.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

34% more capital invested

Capital invested by funds: $20.3M → $27.3M (+$6.99M)

0.04% more ownership

Funds ownership: 0.11% → 0.14% (+0.04%)

11% less funds holding

Funds holding: 57 → 51 (-6)

23% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 22

49% less call options, than puts

Call options by funds: $14.3M | Put options by funds: $28.4M

Holders
51
Holders Change
-6
Holders Change %
-10.53%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
15
Reduced
8
Closed
22
Calls
$14.3M
Puts
$28.4M
Net Calls
-$14M
Net Calls Change
-$6.2M

Top Buyers

Rank Fund Capital Flow
1
Squarepoint
Squarepoint
New York
+$1.97M
2
Morgan Stanley
Morgan Stanley
New York
+$1.65M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.3M
4
Corient Private Wealth
Corient Private Wealth
Florida
+$567K
5
G
Gainplan
Michigan
+$467K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$1.47M
2
JF
Jump Financial
Illinois
-$1.05M
3
UBS Group
UBS Group
Switzerland
-$366K
4
Jane Street
Jane Street
New York
-$274K
5
WEG
World Equity Group
Illinois
-$266K
Name Holding Trade Value Shares
Change 		Change in
Stake
IWC
26
Integrated Wealth Concepts
Massachusetts
$88.8K – – –
PWP
27
Pursue Wealth Partners
California
$88.8K +$93.5K +750 New
EP
28
Edgestream Partners
New Jersey
$83.5K -$190K -1,528 -68%
KA
29
Kovack Advisors
Florida
$82.9K +$6.23K +50 +8%
SWM
30
Spire Wealth Management
Virginia
$71.1K – – –
QC
31
QCM Cayman
Texas
$70.1K +$73.8K +592 New
Belvedere Trading
32
Belvedere Trading
Illinois
$64.1K -$109K -876 -62%
MWM
33
Meridian Wealth Management
Kentucky
$59.9K +$63.1K +506 New
PS
34
PayPay Securities
Japan
$56.5K +$38.4K +308 +182%
UBS Group
35
UBS Group
Switzerland
$49.5K -$366K -2,936 -88%
CG
36
Cutler Group
California
$39K -$56.5K -453 -58%
BCV
37
Banque Cantonale Vaudoise
Switzerland
$36K +$37.4K +300 New
HI
38
Hoey Investments
Pennsylvania
$22.5K +$15.6K +125 +192%
Qube Research & Technologies (QRT)
39
Qube Research & Technologies (QRT)
United Kingdom
$19.2K +$3.86K +31 New
Northwestern Mutual Wealth Management
40
Northwestern Mutual Wealth Management
Wisconsin
$14.8K +$15.6K +125 New
TWM
41
Tradition Wealth Management
Minnesota
$6K +$6.23K +50 New
TRCT
42
Tower Research Capital (TRC)
New York
$4.23K -$155K -1,243 -97%
CPG
43
Cornerstone Planning Group
New Jersey
$4.15K +$4.36K +35 New
QC
44
Quent Capital
New York
$3.55K – – –
2L
45
25 LLC
Missouri
$3.1K – – –
TFM
46
TFC Financial Management
Massachusetts
$2.96K +$3.12K +25 New
Bank of Montreal
47
Bank of Montreal
Ontario, Canada
$2.58K – – –
FDCDDQ
48
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.78K – – –
US Bancorp
49
US Bancorp
Minnesota
$1.78K – – –
MM
50
Main Management
California
$1K – – –
1
2
3

LABU Hedge Fund Activity: Q2 2023 in Review

51 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q2 2023, worth a combined $27.3M — up 34% from $20.3M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LABU and 17 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 15 added.

The largest buyer was Squarepoint, adding an estimated $1.97M. The largest seller was Virtu Financial, exiting entirely with an estimated $1.47M sold.

  • 51 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q2 2023, down from 57 in Q1 2023.
  • Funds reported $27.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q2 2023, up 34% quarter-over-quarter.
  • 17 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q2 2023 and 22 closed out, a net change of -5 holders.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q2 2023 was Squarepoint, an estimated $1.97M added.
  • The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q2 2023 was Virtu Financial, an estimated $1.47M sold.

Based on aggregated 13F filings for Q2 2023.